Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 10, 2026, 2:44 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2137–2160 of 4,345 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Time Management Clear all

Conditions: Behavior, Health
Interventions: Microsteps, Storytelling video, Instructional Video; Behavioral
Lead sponsor: Stanford University; Other
Eligibility: 18 Years to 99 Years
Enrollment: 5,431 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025
U.S. locations: 1
States / cities: Stanford, California

Conditions: Osteoporosis, Spinal Cord Injury
Interventions: Denosumab, Placebo (identical Denosumab volume of normal saline); Drug
Lead sponsor: James J. Peters Veterans Affairs Medical Center; Federal
Eligibility: 18 Years to 65 Years
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2020
U.S. locations: 2
States / cities: West Orange, New Jersey • The Bronx, New York

Conditions: PTEN Gene Mutation, PTEN Hamartoma Tumor Syndrome
Interventions: RAD001, Placebo; Drug
Lead sponsor: Boston Children's Hospital; Other
Eligibility: 5 Years to 45 Years
Enrollment: 46 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2021
U.S. locations: 3
States / cities: Palo Alto, California • Boston, Massachusetts • Cleveland, Ohio

Conditions: Myeloproliferative Neoplasms
Interventions: Ruxolitinib, Decitabine; Drug
Lead sponsor: John Mascarenhas; Other
Eligibility: 18 Years and older
Enrollment: 49 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2018
U.S. locations: 8
States / cities: St Louis, Missouri • Buffalo, New York • New York, New York + 3 more

Conditions: Anxiety Disorder, Depression, Ductal Breast Carcinoma in Situ, Lobular Breast Carcinoma in Situ, Psychosocial Effects of Cancer and Its Treatment, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer, Stage IIIC Breast Cancer
Interventions: educational intervention, counseling intervention, psychosocial support for caregiver; Other
Lead sponsor: University of Washington; Other
Eligibility: Not listed
Enrollment: 108 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2014
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Non-ST Elevation Acute Coronary Syndrome
Interventions: ticagrelor, clopidogrel; Drug
Lead sponsor: AstraZeneca; Industry
Eligibility: 18 Years to 130 Years
Enrollment: 34 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2015
U.S. locations: 8
States / cities: Jacksonville, Florida • Lake Mary, Florida • Macon, Georgia + 5 more

Conditions: Major Depressive Disorder
Interventions: Empagliflozin; Drug
Lead sponsor: NYU Langone Health; Other
Eligibility: 18 Years to 65 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: New York, New York

Conditions: Chronic Nonmalignant Pain, Pain, Intractable, Pain, Chronic
Interventions: Flowonix Prometra® II Programmable Infusion System, Pain Medicine; Device · Drug
Lead sponsor: Evolve Restorative Center; Other
Eligibility: 22 Years and older
Enrollment: 73 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: Santa Rosa, California

Conditions: Substance Abuse, Mental Health, Educational Problems
Interventions: Bridges 4-week Program; Behavioral
Lead sponsor: Arizona State University; Other
Eligibility: 10 Years to 15 Years
Enrollment: 664 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2019
U.S. locations: 1
States / cities: Tempe, Arizona

Conditions: Back Pain Lower Back Chronic, Chronic Pain
Interventions: Buprenorphine Buccal Film [Belbuca], Urine Drug Screening, actigraph, PROMIS 29, sit to stand test, numerical rating scale pain score, patient global impression of function, PROMIS - sleep; Drug · Other · Device + 1 more
Lead sponsor: Carolinas Pain Institute; Other
Eligibility: 18 Years to 65 Years
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Carcinoma, Non-Small-Cell Lung
Interventions: Cyclophosphamide, DRibble vaccine, Imiquimod, GM-CSF, HPV vaccine; Drug · Biological
Lead sponsor: UbiVac; Industry
Eligibility: 18 Years and older
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2017
U.S. locations: 2
States / cities: New Orleans, Louisiana • Portland, Oregon

Conditions: Smoking Cessation, Alcohol Drinking
Interventions: Nicotine Replacement Therapy, Bupropion, Cognitive Behavioral Treatment, Mobile Contingency Management, Mobile Monitoring; Other · Drug · Behavioral
Lead sponsor: Duke University; Other
Eligibility: 18 Years to 80 Years
Enrollment: 45 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2020
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Type 1 Diabetes
Interventions: Transition Social Behavioral Intervention, Diabetes Transition Clinic; Behavioral
Lead sponsor: University of Kansas; Other
Eligibility: 16 Years to 29 Years
Enrollment: 28 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2012
U.S. locations: 1
States / cities: Kansas City, Kansas

Conditions: Chronic Pain
Interventions: Supportive Parenting for Anxious Childhood Emotions - Pain; Behavioral
Lead sponsor: Children's Hospital of Philadelphia; Other
Eligibility: 10 Years to 17 Years
Enrollment: 39 participants
Timeline: 2026 – 2027
U.S. locations: 2
States / cities: Palo Alto, California • Philadelphia, Pennsylvania

Conditions: Patellofemoral Pain Syndrome
Interventions: Hip Progressive Resistive Exercise, Quad Progressive Resistive Exercises; Other
Lead sponsor: Timothy Uhl; Other
Eligibility: 15 Years to 35 Years · Female only
Enrollment: 33 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2010
U.S. locations: 1
States / cities: Lexington, Kentucky

Conditions: Hematopoietic and Lymphoid Cell Neoplasm, Malignant Solid Neoplasm
Interventions: Echocardiogram Recording, Questionnaire Administration, Stress Cardiac Magnetic Resonance Imaging, Wireless Synchronized Cardiac Function Monitoring Device; Procedure · Other · Device
Lead sponsor: City of Hope Medical Center; Other
Eligibility: Not listed
Enrollment: 149 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2026
U.S. locations: 1
States / cities: Duarte, California

Conditions: Acute Lymphoblastic Leukemia, Childhood Acute Lymphoblastic Leukemia
Interventions: Biospecimen Collection, Compliance Monitoring, Health Promotion and Education, Informational Intervention, Media Intervention, Medical Device Usage and Evaluation, Mercaptopurine, Questionnaire Administration, Telephone-Based Intervention, Training and Education; Procedure · Behavioral · Other + 1 more
Lead sponsor: Children's Oncology Group; Network
Eligibility: 10 Years to 25 Years
Enrollment: 64 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 27
States / cities: Birmingham, Alabama • Little Rock, Arkansas • Oakland, California + 20 more

Conditions: Gastrointestinal Cancer, Neuroendocrine Carcinoma, Skin Cancer
Interventions: Aromatherapy and Essential Oils, Subject Diary; Procedure · Other
Lead sponsor: Ohio State University Comprehensive Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 248 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Hematopoietic and Lymphatic System Neoplasm, Malignant Solid Neoplasm
Interventions: Counseling, Health Education, Interview, Medical Chart Review, Monitoring, Questionnaire Administration; Other · Behavioral
Lead sponsor: NRG Oncology; Other
Eligibility: 18 Years and older
Enrollment: 486 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2033
U.S. locations: 30
States / cities: Phoenix, Arizona • Little Rock, Arkansas • Albany, Georgia + 21 more

Conditions: Blood Pressure, Hypertension, Mhealth
Interventions: PACESETTER; Device
Lead sponsor: Northern California Institute of Research and Education; Other
Eligibility: 18 Years to 80 Years
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2024
U.S. locations: 4
States / cities: San Francisco, California • Charleston, South Carolina • Columbia, South Carolina + 1 more

Conditions: Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer
Interventions: OC-L/Montanide ISA 51 VG, Ampligen, Prevnar; Biological
Lead sponsor: Abramson Cancer Center at Penn Medicine; Other
Eligibility: 18 Years and older · Female only
Enrollment: 3 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2012
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Conjunctivitis, Adenoviral Conjunctivitis
Interventions: Betadine 5%, Artificial Tears; Drug
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 18 Years and older
Enrollment: 28 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2018
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Craniopharyngioma
Interventions: Proton Therapy, Surgery; Radiation · Procedure
Lead sponsor: St. Jude Children's Research Hospital; Other
Eligibility: Up to 21 Years
Enrollment: 160 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2028
U.S. locations: 1
States / cities: Memphis, Tennessee

Conditions: Substance Use Disorders, Opioid Use Disorder, Alcohol Use Disorder, Cocaine Use Disorder, Methamphetamine-dependence
Interventions: EDITOR (CBOT with olfactory stimulants, OFC tasks & remote monitoring of treatment compliance), CBOT with olfactory stimulants & OFC tasks, CBOT Sham; Combination Product
Lead sponsor: Evon Medics LLC; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 3
States / cities: Washington D.C., District of Columbia • Rockville, Maryland

Search by objective public record fields.

Microsteps Study-Short, Animated Storytelling Video

Denosumab Administration After Spinal Cord Injury

RAD001 and Neurocognition in PTEN Hamartoma Tumor Syndrome

Study of Combination Ruxolitinib and Decitabine Treatment for Accelerated Phase MPN or Post-MPN AML

Educational Counseling in Improving Communication and Quality of Life in Spouses and Breast Cancer Patients

Ticagrelor vs Clopidogrel in Non-ST Elevation Acute Coronary Syndrome Patients Undergoing PCI With Bivalirudin.

Sodium-Glucose Cotransporter-2 Inhibitor (SGLT2) in Major Depressive Disorder (MDD)

Post-market, Randomized, Controlled, Prospective Study Evaluating Intrathecal Pain Medication (IT) Versus Conventional Medical Management (CMM) in the Non-cancer, Refractory, Chronic Pain Population

Optimizing a Drug Abuse Prevention Program for Dissemination

True Functional Restoration and Analgesia in Non-Radicular Low Back Pain

Combination Vaccine Immunotherapy (DRibbles) for Patients With Definitively-Treated Stage III Non-small Cell Lung Cancer

Mobile Contingency Management for Concurrent Abstinence From Alcohol and Smoking

Transition of Adolescents and Young Adults With Diabetes From Pediatric to Adult Care

SPACE for Youth With Chronic Pain

Comparing Rehabilitation Programs for Patellofemoral Pain Syndrome

Reproducibility and Accuracy of a Portable System for Early Detection of Cardiac Dysfunction in Childhood Cancer Survivors

A Study of Different Programs to Help ALL Patients With Taking Maintenance Medicine at Home

Inhaled Essential Oil Effect on Common QOL Concerns During Cancer Treatment

Comparing Telephone Symptom Monitoring Interventions for Managing Symptoms and Psychological Distress During Oral Anti-Cancer Treatment

PACESETTER: Program to Avoid Cerebrovascular Events Through Systematic Electronic Tracking and Tailoring of an Eminent Risk-factor

A Clinical Trial of Autologous Oxidized Tumor Cell Lysate Vaccine For Recurrent Ovarian, Fallopian Tube or Primary Peritoneal Cancer

Reducing Adenoviral Patient Infected Days

A Phase II Trial of Intensity-Modulated Proton Therapy for Incompletely Resected Craniopharyngioma and Observation for Craniopharyngioma After Radical Resection

Enhanced Digital-Chemosensory-Based Olfactory Training for Remote Management of Substance Use Disorders